Public Profile

Longzen Pharmaceutical

Longzen Pharmaceutical Co., Ltd., commonly referred to as Longzen Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 2005, the company has made significant strides in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of oncology and cardiovascular health. With a strong operational presence across Asia and expanding into global markets, Longzen Pharma is dedicated to delivering high-quality medications that address critical health challenges. Their core offerings include advanced formulations and generics, distinguished by their commitment to research and development, ensuring efficacy and safety. Recognised for its robust market position, Longzen Pharma has achieved notable milestones, including several international certifications and partnerships that enhance its reputation as a trusted provider in the healthcare sector.

DitchCarbon Score

How does Longzen Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Longzen Pharmaceutical's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Longzen Pharmaceutical's reported carbon emissions

Longzen Pharmaceutical, headquartered in CN, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Longzen Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Longzen to establish clear emissions reduction goals and commitments to align with global climate standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Longzen Pharmaceutical's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Longzen Pharmaceutical is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Longzen Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Chemicals

PROVEQUIM

EC
Chemicals
Updated 10 days ago

Dial International, Inc

US
Chemicals
Updated 3 days ago

Air Liquide Medicinal, S.A.

PT
Chemicals
Updated 3 days ago

Kci

KR
Chemicals
Updated 10 days ago

UNGERER MEXICO

MX
Chemicals
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers